Advancing RNA, Gene Editing & Targeted Genetic Therapies in PKD to Address Disease at its Source & Deliver Durable Benefit
11:00 am - Tuesday 16th March 2027
- Comparing mutation-specific, RNA and gene-based approaches emerging across PKD
- Overcoming delivery challenges to reach the relevant kidney cell populations safely
- Designing development strategies that can accommodate increasingly narrow genetic subgroups